What is the CVSS score of CVE-2025-21570?

CVE-2025-21570 has a CVSS 3.1 base score of 6.1 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N. EPSS exploitation probability: 0.3%.

Which versions of Argus Safety are affected by CVE-2025-21570?

CVE-2025-21570 presents moderate security risk, a incorrect authorization vulnerability rated CVSS 6.1. Attackers could gain access beyond their authorized level.

How to fix or mitigate CVE-2025-21570?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Argus Safety CVE-2025-21570

MEDIUM

Incorrect Authorization (CWE-863)

2025-01-21 secalert_us@oracle.com

Authentication Bypass Oracle Argus Safety

6.1

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.1 MEDIUM

AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

Required

Scope

Changed

Confidentiality

Low

Integrity

Low

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 28, 2026 - 18:04 vuln.today

CVE Published

Jan 21, 2025 - 21:15 nvd

MEDIUM 6.1

DescriptionCVE.org

Vulnerability in the Oracle Life Sciences Argus Safety product of Oracle Health Sciences Applications (component: Login). The supported version that is affected is 8.2.3. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Argus Safety. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Life Sciences Argus Safety, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Argus Safety accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Argus Safety accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N).

AnalysisAI

Vulnerability in the Oracle Life Sciences Argus Safety product of Oracle Health Sciences Applications (component: Login). Rated medium severity (CVSS 6.1), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Incorrect Authorization (CWE-863), which allows attackers to bypass authorization checks to access restricted resources. Vulnerability in the Oracle Life Sciences Argus Safety product of Oracle Health Sciences Applications (component: Login). The supported version that is affected is 8.2.3. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Argus Safety. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Life Sciences Argus Safety, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Argus Safety accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Argus Safety accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N). Affected products include: Oracle Argus Safety.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Review and test authorization logic, implement consistent access control checks, use centralized authorization framework.